New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance

Biochemistry, Genetics and Molecular Biology

• Myeloid 100%
• Imatinib 100%
• Introspection 100%
• Kinase 50%
• Tyrosine Kinase Inhibitor 33%
• Development 16%
• Isoform 16%
• Fusion Protein 16%
• Src Family Kinase 16%
• Dasatinib 16%
• Nilotinib 16%
• Methanesulfonic Acid 16%
• Light 16%
• Genetics 16%
• Mutant 16%
• ABL (Gene) 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Pathophysiology 100%
• Chronic Myeloid Leukemia 100%
• Imatinib 100%
• Diseases 33%
• Disease Exacerbation 33%
• Phosphotransferase 33%
• Protein Tyrosine Kinase Inhibitor 33%
• Nilotinib 33%
• Pathogenesis 16%
• Dasatinib 16%
• Phosphotransferase Inhibitor 16%
• Protein Tyrosine Kinase 16%
• Fusion Protein 16%
• Cancer Chemotherapy 16%

INIS

• kinases 100%
• myeloid leukemia 100%
• diseases 66%
• patients 33%
• therapy 33%
• tyrosine 33%
• genetics 16%
• cancer 16%
• humans 16%
• proteins 16%
• genes 16%
• reviews 16%
• pathogenesis 16%
• mutants 16%
• amplification 16%
• chemotherapy 16%